Corrigendum: In vivo detection of metabolic 2H-incorporation upon ingestion of 2H2O : Journal of Bio-X Research

Secondary Logo

Journal Logo

Corrigendum

Corrigendum: In vivo detection of metabolic 2H-incorporation upon ingestion of 2H2O

Author Information
doi: 10.1097/JBR.0000000000000129
  • Open

In the article titled “In vivo detection of metabolic 2H-incorporation upon ingestion of 2H2O” (DOI 10.1097/JBR.0000000000000121),[1] the information in the “Conflicts of Interest” section is incomplete. The complete and correct information about the Conflicts of Interest is as follows:

PS and KDS are cofounders of Deep Breath Intelligence AG (Switzerland), which develops breath-based diagnostic tools. KDS is consultant for Deep Breath Intelligence AG (Switzerland). All the other authors declare no competing interests. The concept of monitoring metabolic 2H-incorporation non-invasively and in vivo via SESI-HRMS has been incorporated as a patent with the title “Mass spectrometry Method and System” in the China Intellectual Property Office PCT/CN2022/075436, filed on February 8th, 2022.

The authors apologize for any inconvenience this correction may cause for readers and editors of Journal of Bio-X Research.

Reference

[1]. Arnold K, Chen X, Zhang H, et al. In vivo detection of metabolic 2H-incorporation upon ingestion of 2H2O. J Bio-X Res. 2022;5:81–89.
Copyright © 2022 The Chinese Medical Association, Published by Wolters Kluwer Health, Inc.